The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20040317
Fujii et al.

Figure S1 Cytokine production by splenic DCs after i.v. {alpha}-GalCer.

Figure S2 Weak contribution of individual inflammatory cytokines in the {alpha}-GalCer induced remodeling of the DC surface, shown here for CD80, -86, and -40.

Figure S3 Role of CD40L in the response to {alpha}-GalCer.

Figure S4 Bone marrow chimeras were prepared in irradiated mice, and expression of MHC class I (H-2Kb) was used to monitor reconstitution of TAP-/- cells.

Figure S5 IL-12 p40 is not required to induce OVA-specific immunity DCs maturing to {alpha}-GalCer.

Figure S6 The observed responses to a single i.v. dose of {alpha}-GalCer.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS